Asteroid hyalosis (AH) is a common, often benign, ophthalmic condition characterized by the presence of bright, yellow-white particles suspended within the vitreous humor. These particles, known as asteroid bodies (ABs), are composed of lipids and calcium, giving them a star-like appearance against the dark fundus, hence the name “asteroid.” While typically asymptomatic and often discovered during routine eye examinations, asteroid hyalosis can sometimes obscure the fundus and require differentiation from other vitreous opacities. Accurate diagnosis is crucial to avoid unnecessary interventions and to rule out more serious conditions. This article aims to provide a comprehensive overview of the differential diagnosis of asteroid hyalosis, emphasizing key distinctions from other vitreous pathologies and guiding clinicians in appropriate evaluation and management.
Understanding Asteroid Hyalosis: Etiology and Prevalence
The precise cause of asteroid hyalosis remains unknown, although several theories have been proposed. Early hypotheses suggested a link to systemic vascular disease, proposing that arteriosclerosis in ocular vessels could lead to localized lipid and fat deposition within the vitreous. Other theories involve the degeneration of retinal cells releasing phospholipids and calcium, or exogenous sources contributing to AB formation. Despite these theories, a definitive etiology remains elusive.
Epidemiologically, asteroid hyalosis is a relatively common finding, with prevalence rates ranging from 0.8% to 2.0% in the adult population. Studies indicate a clear association with increasing age, with prevalence rising significantly in older age groups. While some studies suggest a slight male predominance, others have not found a significant gender difference. Asteroid hyalosis is typically unilateral, affecting one eye in 75% to 90% of cases, and is not considered to be hereditary, with familial occurrences being rare.
Pathophysiology and Histopathology of Asteroid Bodies
The pathophysiology of asteroid hyalosis is complex and not fully understood. The unilateral nature of the condition suggests local factors within the eye may play a significant role, potentially involving localized inflammation, retinal pigment epithelium degeneration, pH changes, or alterations in vitreous collagen. Changes in retinal vascular permeability might also contribute by affecting calcium and lipid levels in the vitreous.
Histopathological studies have extensively analyzed the composition of asteroid bodies. The consensus is that they are primarily composed of calcium-associated phospholipids. Energy-dispersive X-ray spectroscopy (EDX) has confirmed the presence of calcium and phosphorus, and lipid stains react strongly with ABs. Further detailed biochemical analyses have identified components such as sphingomyelin, cholesterol, and various lipids. Ultrastructural analysis reveals ABs as intertwined multilaminar membranes with a characteristic periodicity, further supporting their complex lipid nature. More recent studies using advanced microscopy techniques have refined our understanding, pointing towards hydroxyapatite-like structures composed of calcium, phosphorus, and oxygen within the asteroid bodies. These findings suggest a complex interplay of lipid and mineral components in the formation of these vitreous opacities.
Clinical Presentation and Ophthalmic Evaluation
Patients with asteroid hyalosis are often asymptomatic. The condition is frequently discovered incidentally during routine ophthalmoscopic examinations. Due to the relatively small size of asteroid bodies and their smooth surfaces, they cause minimal light scattering. However, if ABs are located close to the macula or become concentrated following a posterior vitreous detachment, they can become visually symptomatic, manifesting as floaters.
Alt text: Slit-lamp biomicroscopy demonstrating the mobile nature of asteroid bodies within the vitreous humor during eye movement in a patient with asteroid hyalosis.
Ophthalmoscopic examination reveals asteroid bodies as small, round, refractile opacities suspended within the vitreous cavity. These particles exhibit a characteristic “snow globe” appearance, moving with vitreous movement but returning to their original positions and not settling with gravity. Their size can vary from 3 to 100 microns. Direct ophthalmoscopy often provides a better view of the fundus compared to indirect ophthalmoscopy or slit-lamp biomicroscopy because it minimizes light reflection from the asteroid bodies.
In patients with diabetes and asteroid hyalosis, fundus fluorescein angiography (FFA) may be necessary, particularly if neovascularization is suspected. Wide-angle FFA can be valuable for detecting peripheral retinal lesions. Optical coherence tomography angiography (OCTA) is increasingly used as an alternative to FFA. Optical coherence tomography (OCT) is helpful in evaluating the vitreoretinal interface. Swept-source OCT is superior to spectral-domain OCT in penetrating media opacities caused by AH. B-scan ultrasonography is a useful adjunct, showing moderate to high amplitude point spikes in the vitreous, separated from the retinal surface by a clear zone. Multicolor fundus imaging can also enhance the detection of subtle retinal lesions obscured by asteroid bodies.
Alt text: B-scan ultrasonography of an eye with asteroid hyalosis, illustrating the characteristic high-amplitude, punctate echoes within the vitreous cavity, distinct from the retinal surface.
Differential Diagnosis: Distinguishing Asteroid Hyalosis from Other Vitreous Opacities
The primary importance of understanding asteroid hyalosis lies in its differential diagnosis. While AH is typically benign, it’s crucial to distinguish it from other conditions that present with vitreous opacities, some of which may require intervention. Key differential diagnoses include:
1. Synchysis Scintillans (Cholesterolosis Bulbi)
Synchysis scintillans, also known as cholesterolosis bulbi, is another degenerative condition characterized by vitreous opacities. However, unlike the fixed, suspended particles of asteroid hyalosis, synchysis scintillans involves freely mobile, refractile cholesterol crystals within a liquefied vitreous cavity. These crystals are typically flatter and more angular than asteroid bodies and exhibit a characteristic “gold dust” or “sparkling” appearance. Crucially, in synchysis scintillans, these crystals settle inferiorly with gravity when the eye is stationary, a key differentiating factor from asteroid hyalosis. Synchysis scintillans is often associated with phthisis bulbi, intraocular hemorrhage, or other degenerative eye conditions, typically occurring in eyes with a history of significant ocular pathology or trauma.
2. Vitreous Amyloidosis
Vitreous amyloidosis involves the deposition of amyloid fibrils within the vitreous. This condition is often bilateral and more visually symptomatic than asteroid hyalosis, typically presenting with a gradual decline in vision due to vitreous opacity. The opacities in amyloidosis are often described as “glass wool” or “string of pearls,” appearing as vitreous strands or sheets. Unlike the bright, refractile particles of AH, amyloid opacities are more diffuse and less reflective. Diagnosis of vitreous amyloidosis is confirmed through vitreous biopsy and histopathological examination revealing amyloid deposits. Systemic associations, particularly familial amyloid polyneuropathy, should be considered in cases of vitreous amyloidosis.
3. Vitritis (Vitreous Inflammation)
Vitritis, or vitreous inflammation, is characterized by inflammatory cells and debris within the vitreous humor. This condition is typically associated with active inflammation and presents with symptoms such as blurred vision, floaters, and potentially pain and redness in the eye, unlike the usually asymptomatic nature of asteroid hyalosis. Ophthalmoscopic examination in vitritis reveals vitreous haze due to inflammatory cells, which can range from subtle to dense. Anterior chamber inflammation (uveitis) and retinal findings (retinitis, choroiditis) are often present in conjunction with vitritis, helping to distinguish it from AH. The clinical history and associated symptoms of inflammation are key differentiators.
4. Old Vitreous Hemorrhage
Residual vitreous hemorrhage can sometimes mimic vitreous opacities. However, a history of retinal vascular disease (e.g., diabetic retinopathy), trauma, or posterior vitreous detachment leading to hemorrhage is usually present. The appearance of vitreous hemorrhage varies depending on its age. Fresh hemorrhage appears as red blood within the vitreous, while older hemorrhage may appear more yellow or brown as blood breaks down. Unlike the refractile particles of asteroid hyalosis, vitreous hemorrhage is typically less reflective and more diffuse. Careful ophthalmoscopy, potentially with scleral depression, and review of patient history are crucial for differentiation. B-scan ultrasonography can be particularly helpful in cases of dense vitreous opacity to rule out retinal detachment or other underlying causes of hemorrhage.
5. Intraocular Lymphoma and Masquerade Syndromes
In rare instances, asteroid hyalosis needs to be differentiated from more serious conditions like intraocular lymphoma or masquerade syndromes, particularly retinoblastoma in children. Intraocular lymphoma can present with vitreous opacities, but these are typically more cellular and less refractile than asteroid bodies. Lymphoma may also be associated with uveitis and retinal infiltrates. Masquerade syndromes are conditions that mimic uveitis or other inflammatory conditions, and lymphoma is a significant consideration in this category. Retinoblastoma, especially in young children, can rarely be mimicked by AH, although this is highly unusual. If there is any atypical presentation, suspicion of malignancy, or lack of typical AH characteristics, further investigation, including vitreous biopsy for cytology, may be warranted.
6. Other Rare Vitreous Opacities
While less common, other conditions can cause vitreous opacities that may enter the differential diagnosis. These include:
- Vitreous opacities secondary to medications: Certain medications can rarely cause crystalline or other deposits in the vitreous.
- Infectious vitritis (e.g., fungal, bacterial): While generally presenting with more pronounced inflammation, subtle infectious vitritis could be considered in the differential.
- Vitreous condensations: Age-related vitreous syneresis can lead to vitreous strands and condensations, which, while different in appearance from AH, may need to be distinguished in some cases.
Management and Prognosis
Asteroid hyalosis is generally a benign condition that requires observation only. Since most patients are asymptomatic, no active treatment is typically necessary. However, it is crucial to ensure that the diagnosis is accurate and that no underlying or coexisting retinal pathology is missed due to obscured fundus view. In cases where asteroid hyalosis significantly impairs visualization of the fundus, particularly in patients with diabetic retinopathy or other retinal conditions requiring monitoring or treatment (like laser photocoagulation), pars plana vitrectomy may be considered to clear the vitreous opacities and allow for adequate fundus examination and treatment. Vitrectomy is also rarely indicated for visually symptomatic floaters directly attributable to AH, though this is uncommon.
Cataract surgery in patients with asteroid hyalosis requires specific considerations. Preoperative A-scan biometry may be inaccurate due to reflections from asteroid bodies, potentially leading to falsely short axial length measurements. Careful comparison with the axial length of the fellow eye is recommended. During surgery, reflections from ABs can hinder visualization of the posterior capsule. Silicone intraocular lenses (IOLs) were historically cautioned against due to reports of calcium and phosphorus deposition on their surface, although this is now considered less of a contraindication with modern IOL materials and techniques. If silicone IOL opacification occurs, laser capsulotomy or IOL exchange may be considered.
The prognosis for asteroid hyalosis is excellent, as it is typically a non-progressive and benign condition that does not directly cause visual impairment or complications. However, the presence of coexisting ophthalmic conditions, such as diabetic retinopathy or retinal detachment, will dictate the overall visual prognosis. Careful and accurate diagnosis, particularly differentiating AH from other vitreous opacities, is key to appropriate management and ensuring optimal patient outcomes.
Enhancing Healthcare Team Outcomes
Effective management of patients with asteroid hyalosis relies on a collaborative interprofessional healthcare team. Optometrists and ophthalmologists play a crucial role in diagnosis and monitoring. Given the potential associations with systemic conditions like diabetes and hypertension, communication with primary care physicians and endocrinologists is important for comprehensive patient care. Ophthalmology nurses contribute significantly to patient education, follow-up, and coordinating care. Operating room nurses are essential if surgical intervention, such as vitrectomy or cataract surgery, becomes necessary. This coordinated approach ensures accurate diagnosis, appropriate management of associated systemic conditions, and optimal patient outcomes.
References
1.Tripathy K. Asteroid Hyalosis. N Engl J Med. 2018 Aug 23;379(8):e12. [PubMed: 30134134]
2.Bergren RL, Brown GC, Duker JS. Prevalence and association of asteroid hyalosis with systemic diseases. Am J Ophthalmol. 1991 Mar 15;111(3):289-93. [PubMed: 2000898]
3.Moss SE, Klein R, Klein BE. Asteroid hyalosis in a population: the Beaver Dam eye study. Am J Ophthalmol. 2001 Jul;132(1):70-5. [PubMed: 11438056]
4.Fawzi AA, Vo B, Kriwanek R, Ramkumar HL, Cha C, Carts A, Heckenlively JR, Foos RY, Glasgow BJ. Asteroid hyalosis in an autopsy population: The University of California at Los Angeles (UCLA) experience. Arch Ophthalmol. 2005 Apr;123(4):486-90. [PubMed: 15824221]
5.RODMAN HI, JOHNSON FB, ZIMMERMAN LE. New histo-pathological and histochemical observations concerning asteroid hyalitis. Arch Ophthalmol. 1961 Oct;66:552-63. [PubMed: 14493131]
6.Streeten BW. Vitreous asteroid bodies. Ultrastructural characteristics and composition. Arch Ophthalmol. 1982 Jun;100(6):969-75. [PubMed: 7092637]
7.Zauberman H, Livni N. Experimental vascular occlusion in hypercholesterolemic rabbits. Invest Ophthalmol Vis Sci. 1981 Aug;21(2):248-55. [PubMed: 7251308]
8.Winkler J, Lünsdorf H. Ultrastructure and composition of asteroid bodies. Invest Ophthalmol Vis Sci. 2001 Apr;42(5):902-7. [PubMed: 11274065]
9.Feldman GL. Human ocular lipids: their analysis and distribution. Surv Ophthalmol. 1967 Jun;12(3):207-43. [PubMed: 4867603]
10.March WF, Shoch D. Electron diffraction study of asteroid bodies. Invest Ophthalmol. 1975 May;14(5):399-400. [PubMed: 165161]
11.Topilow HW, Kenyon KR, Takahashi M, Freeman HM, Tolentino FI, Hanninen LA. Asteroid hyalosis. Biomicroscopy, ultrastructure, and composition. Arch Ophthalmol. 1982 Jun;100(6):964-8. [PubMed: 7092636]
12.Komatsu H, Kamura Y, Ishi K, Kashima Y. Fine structure and morphogenesis of asteroid hyalosis. Med Electron Microsc. 2003 Jun;36(2):112-9. [PubMed: 12825125]
13.Lin SY, Chen KH, Cheng WT, Ho CT, Wang SL. Preliminary identification of Beta-carotene in the vitreous asteroid bodies by micro-Raman spectroscopy and HPLC analysis. Microsc Microanal. 2007 Apr;13(2):128-32. [PubMed: 17367552]
14.Luxenberg M, Sime D. Relationship of asteroid hyalosis to diabetes mellitus and plasma lipid levels. Am J Ophthalmol. 1969 Mar;67(3):406-13. [PubMed: 5774257]
15.Safir A, Dunn SN, Martin RG, Tate GW, Mincey GJ. Is asteroid hyalosis ocular gout? Ann Ophthalmol. 1990 Feb;22(2):70-7. [PubMed: 2316956]
16.Khoshnevis M, Rosen S, Sebag J. Asteroid hyalosis-a comprehensive review. Surv Ophthalmol. 2019 Jul-Aug;64(4):452-462. [PubMed: 30707924]
17.Hampton GR, Nelsen PT, Hay PB. Viewing through the asteroids. Ophthalmology. 1981 Jul;88(7):669-72. [PubMed: 7267035]
18.Motiani MV, McCannel CA, Almanzor R, McCannel TA. Diagnosis of Choroidal Melanoma in Dense Asteroid Hyalosis. Semin Ophthalmol. 2017;32(2):257-259. [PubMed: 27058861]
19.Rani PK, Prajapati RC. Role of OCT Angiography in the Detection of Retinal Vascular and Macular Abnormalities in Subjects with Asteroid Hyalosis. Semin Ophthalmol. 2019 Jan 02;34(1):42-46. [PubMed: 30475665]
20.Ogino K, Murakami T, Yoshimura N. Photocoagulation guided by wide-field fundus autofluorescence in eyes with asteroid hyalosis. Eye (Lond). 2014 May;28(5):634-5. [PMC free article: PMC4017121] [PubMed: 24603417]
21.Hwang JC, Barile GR, Schiff WM, Ober MD, Smith RT, Del Priore LV, Turano MR, Chang S. Optical coherence tomography in asteroid hyalosis. Retina. 2006 Jul-Aug;26(6):661-5. [PMC free article: PMC2771563] [PubMed: 16829809]
22.Alasil T, Adhi M, Liu JJ, Fujimoto JG, Duker JS, Baumal CR. Spectral-domain and swept-source OCT imaging of asteroid hyalosis: a case report. Ophthalmic Surg Lasers Imaging Retina. 2014 Sep-Oct;45(5):459-61. [PMC free article: PMC4712921] [PubMed: 25230400]
23.Kachewar SG, Kulkarni DS. An Imaging Review of Intra-ocular Calcifications. J Clin Diagn Res. 2014 Jan;8(1):203-5. [PMC free article: PMC3939552] [PubMed: 24596775]
24.Saurabh K, Roy R, Chowdhury M. Efficacy of Multicolor Imaging in Patients With Asteroid Hyalosis: Seeing the Unseen. JAMA Ophthalmol. 2018 Apr 01;136(4):446-447. [PMC free article: PMC5876890] [PubMed: 29522059]
25.van den Born LI, van Soest S, van Schooneveld MJ, Riemslag FC, de Jong PT, Bleeker-Wagemakers EM. Autosomal recessive retinitis pigmentosa with preserved para-arteriolar retinal pigment epithelium. Am J Ophthalmol. 1994 Oct 15;118(4):430-9. [PubMed: 7943119]
26.Dodwell DG, Freeman K, Shoch D. Juvenile asteroid hyalosis and pre-Descemet’s dystrophy. Am J Ophthalmol. 1988 Oct 15;106(4):504-5. [PubMed: 3263047]
27.Ikeda Y, Hisatomi T, Murakami Y, Miyazaki M, Kohno R, Takahashi H, Hata Y, Ishibashi T. Retinitis pigmentosa associated with asteroid hyalosis. Retina. 2010 Sep;30(8):1278-81. [PubMed: 20827143]
28.Burris CKH, Azari AA, Kanavi MR, Dubielzig RR, Lee V, Gottlieb JL, Potter HD, Kim K, Raven ML, Rodriguez ME, Reddy DN, Albert DM. Is There an Increased Prevalence of Asteroid Hyalosis in Eyes with Uveal Melanoma? A Histopathologic Study. Ocul Oncol Pathol. 2017 Nov;3(4):259-261. [PMC free article: PMC5757614] [PubMed: 29344477]
29.Mouna A, Berrod JP, Conart JB. Visual Outcomes of Pars Plana Vitrectomy with Epiretinal Membrane Peeling in Patients with Asteroid Hyalosis: A Matched Cohort Study. Ophthalmic Res. 2017;58(1):35-39. [PubMed: 28463846]
30.Martin RG, Safir A. Asteroid hyalosis affecting the choice of intraocular lens implant. J Cataract Refract Surg. 1987 Jan;13(1):62-5. [PubMed: 3550044]
31.Wackernagel W, Ettinger K, Weitgasser U, Bakir BG, Schmut O, Goessler W, Faschinger C. Opacification of a silicone intraocular lens caused by calcium deposits on the optic. J Cataract Refract Surg. 2004 Feb;30(2):517-20. [PubMed: 15030853]
32.Lee YJ, Han SB. Laser treatment of silicone intraocular lens opacification associated with asteroid hyalosis. Taiwan J Ophthalmol. 2019 Jan-Mar;9(1):49-52. [PMC free article: PMC6432846] [PubMed: 30993069]
33.Platt SM, Iezzi R, Mahr MA, Erie JC. Surgical removal of dystrophic calcification on a silicone intraocular lens in association with asteroid hyalosis. J Cataract Refract Surg. 2017 Dec;43(12):1608-1610. [PubMed: 29335107]
34.Espandar L, Mukherjee N, Werner L, Mamalis N, Kim T. Diagnosis and management of opacified silicone intraocular lenses in patients with asteroid hyalosis. J Cataract Refract Surg. 2015 Jan;41(1):222-5. [PubMed: 25532646]
35.Sebag J, Yee KMP, Nguyen JH, Nguyen-Cuu J. Long-Term Safety and Efficacy of Limited Vitrectomy for Vision Degrading Vitreopathy Resulting from Vitreous Floaters. Ophthalmol Retina. 2018 Sep;2(9):881-887. [PubMed: 31047219]
36.Okuda Y, Kakurai K, Sato T, Morishita S, Fukumoto M, Kohmoto R, Takagi M, Kobayashi T, Kida T, Ikeda T. Two Cases of Rhegmatogenous Retinal Detachment Associated with Asteroid Hyalosis. Case Rep Ophthalmol. 2018 Jan-Apr;9(1):43-48. [PMC free article: PMC5892340] [PubMed: 29643781]
37.Renaldo DP. Pars plana vitrectomy for asteroid hyalosis. Retina. 1981;1(3):252-4. [PubMed: 7348845]
38.Lambrou FH, Sternberg P, Meredith TA, Mines J, Fine SL. Vitrectomy when asteroid hyalosis prevents laser photocoagulation. Ophthalmic Surg. 1989 Feb;20(2):100-2. [PubMed: 2927889]
39.Williams BK, Elimimian EB, Shields CL. Asteroid Hyalosis Simulating Vitreous Seeds in a Patient With Retinoblastoma. J Pediatr Ophthalmol Strabismus. 2019 Jul 05;56:e41-e44. [PubMed: 31282959]
Disclosure: Chitaranjan Mishra declares no relevant financial relationships with ineligible companies.
Disclosure: Koushik Tripathy declares no relevant financial relationships with ineligible companies.